Patent Highlights From December 2017 to January 2018

References

• Nash LA Burns JK Chardon JW Kothary R Parks RJ . Spinal muscular atrophy: more than a disease of motor neurons?Curr. Mol. Med.16 (9), 779–792 (2016).
   PubMed Web of Science ®Google Scholar
• Bordet T Berna P Abitbol JL Pruss RM . Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals (Basel)3 (2), 345–368 (2010).
   PubMedGoogle Scholar
• Bertini E Dessaud E Mercuri E et al. Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled Phase II trial. Lancet Neurol.16 (7), 513–522 (2017).
   PubMed Web of Science ®Google Scholar
• Lenglet T Lacomblez L Abitbol JL et al. A Phase II–III trial of olesoxime in subjects with amyotrophic lateral sclerosis. Eur. J. Neurol.21 (3), 529–536 (2014).
   PubMed Web of Science ®Google Scholar
• Bowerman M Murrray LM Scamps F Schneider BL Kothary R Raoul C . Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: converging roads to therapeutic development. Eur. J. Med. Genet. doi:10.1016/j.ejmg.2017.12.001 (2017) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Corral L Hanke T Vance RE Cado D Raulet DH . NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur. J. Immunol.30 (3), 920–930 (2000).
   PubMed Web of Science ®Google Scholar
• Robbins SH Terrizzi SC Sydora BC Mikayama T Brossay L . Differential regulation of killer cell lectin-like receptor G1 expression on T cells. J. Immunol.170 (12), 5876–5885 (2003).
   PubMed Web of Science ®Google Scholar
• Kornete M Mason E Istomine R Piccirillo CA . KLRG1 expression identifies short-lived Foxp3 + Treg effector cells with functional plasticity in islets of NOD mice. Autoimmunity50 (6), 354–362 (2017).
   PubMed Web of Science ®Google Scholar
• Brandi ML Hukkanen M Umeda T et al. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc. Natl Acad. Sci. USA92 (7), 2954–2958 (1995).
   PubMed Web of Science ®Google Scholar
• Nabhan AF Rabie NH . Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis. Int. J. Gynaecol. Obstet.103 (3), 213–216 (2008).
   PubMed Web of Science ®Google Scholar
• Bucur RC Reid LS Hamilton CJ Cummings SR Jamal SA . Nitrates and bone turnover (NABT) – trial to select the best nitrate preparation: study protocol for a randomized controlled trial. Trials14, 284 (2013).
   PubMedGoogle Scholar
• Broderick KE Alvarez L Balasubramanian M et al. Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo. Exp. Biol. Med. (Maywood)232 (11), 1432–1440 (2007).
   PubMed Web of Science ®Google Scholar
• Kalyanaraman H Ramdani G Joshua J et al. A novel, direct no donor regulates osteoblast and osteoclast functions and increases bone mass in ovariectomized mice. J. Bone Miner. Res.32 (1), 46–59 (2017).
   PubMed Web of Science ®Google Scholar
• Wang P Li J Tao J Sha B . The luminal domain of the ER stress sensor protein PERK binds misfolded proteins and thereby triggers PERK oligomerization. J. Biol. Chem.293 (11), 4110–4121 (2018).
   PubMed Web of Science ®Google Scholar
• Halliday M Hughes D Mallucci GR . Fine-tuning PERK signaling for neuroprotection. J. Neurochem. doi:10.1111/jnc.14112 (2017) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Leitman J Barak B Benyair R et al. ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin. PLoS ONE9 (3), e90803 (2014).
   PubMed Web of Science ®Google Scholar
• Wang H Blais J Ron D Cardozo T . Structural determinants of PERK inhibitor potency and selectivity. Chem. Biol. Drug Des.76 (6), 480–495 (2010).
   PubMed Web of Science ®Google Scholar
• Varnholt H Drebber U Schulze F et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology47 (4), 1223–1232 (2018).
   Google Scholar
• Marin-Muller C Li D Bharadwaj U et al. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin. Cancer Res.19 (21), 5901–5913 (2013).
   PubMed Web of Science ®Google Scholar
• Sundaram GM Common JE Gopal FE et al. ‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature495 (7439), 103–106 (2013).
   PubMed Web of Science ®Google Scholar
• Sundaram GM Ismail HM Bashir M et al. EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis. J. Exp. Med.214 (10), 2889–2900 (2017).
   PubMed Web of Science ®Google Scholar
• Yang JW Kim HS Choi YW Kim YM Kang KW . Therapeutic application of GPR119 ligands in metabolic disorders. Diabetes Obes. Metab.20 (2), 257–269 (2018).
   PubMed Web of Science ®Google Scholar
• Cornall LM Mathai ML Hryciw DH McAinch AJ . Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?Expert Opin. Investig. Drugs22 (4), 487–498 (2013).
   PubMed Web of Science ®Google Scholar
• Miller S Hu SS Leishman E et al. A GPR119 signaling system in the murine eye regulates intraocular pressure in a sex-dependent manner. Invest. Ophthalmol. Vis. Sci.58 (7), 2930–2938 (2017).
   PubMed Web of Science ®Google Scholar
• van Riel B Rosenbauer F . Epigenetic control of hematopoiesis: the PU.1 chromatin connection. Biol. Chem.395 (11), 1265–1274 (2014).
   PubMed Web of Science ®Google Scholar
• Chmielewski S Piaszyk-Borychowska A Wesoly J Bluyssen HA . STAT1 and IRF8 in vascular inflammation and cardiovascular disease: diagnostic and therapeutic potential. Int. Rev. Immunol.35 (5), 434–454 (2016).
   PubMed Web of Science ®Google Scholar
• Kanno Y Levi BZ Tamura T Ozato K . Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J. Interferon Cytokine Res.25 (12), 770–779 (2005).
   PubMed Web of Science ®Google Scholar
• Munde M Wang S Kumar A et al. Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines. Nucleic Acids Res.42 (2), 1379–1390 (2014).
   PubMed Web of Science ®Google Scholar
• Ferraz MJ Marques AR Appelman MD et al. Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases. FEBS Lett.590 (6), 716–725 (2016).
   PubMed Web of Science ®Google Scholar
• Lukas J Cozma C Yang F et al. Glucosylsphingosine causes hematological and visceral changes in mice-evidence for a pathophysiological role in gaucher disease. Int. J. Mol. Sci.18 (10), e2192 (2017).
   PubMed Web of Science ®Google Scholar
• Rolfs A Giese AK Grittner U et al. Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. PLoS ONE8 (11), e79732 (2013).
   PubMed Web of Science ®Google Scholar
• Gegg ME Schapira AHV . The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J. doi:10.1111/febs.14393 (2018) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Kickhoefer VA Searles RP Kedersha NL Garber ME Johnson DL Rome LH . Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J. Biol. Chem.268 (11), 7868–7873 (1993).
   PubMed Web of Science ®Google Scholar
• Chen J OuYang H An X Liu S . Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6. PLoS ONE13 (1), e0191325 (2018).
   PubMed Web of Science ®Google Scholar
• Banerjee Dixit A Sharma D Srivastava A et al. Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy. Seizure47, 9–12 (2017).
   PubMed Web of Science ®Google Scholar
• Li F Chen Y Zhang Z et al. Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity. Nucleic Acids Res.43 (21), 10321–10337 (2015).
   PubMed Web of Science ®Google Scholar
• Long M Li X Li L Dodson M Zhang DD Zheng H . Multifunctional p62 effects underlie diverse metabolic diseases. Trends Endocrinol. Metab.28 (11), 18–830 (2017).
   Web of Science ®Google Scholar
• Goldberg J Jin Q Ambroise Y et al. Erythropoietin mimetics derived from solution phase combinatorial libraries. J. Am. Chem. Soc.124 (4), 544–555 (2002).
   PubMed Web of Science ®Google Scholar
• Su L Wang Y Morin MD et al. Structural characterization of TLRs with novel agonists. J. Immunol.198 (S1), 129.4 (2017).
   Google Scholar
• Pisanic TR 2nd Zhang Y Wang TH . Quantum dots in diagnostics and detection: principles and paradigms. Analyst139 (12), 2968–2981 (2014).
   PubMed Web of Science ®Google Scholar
• Rizvi SB Rouhi S Taniguchi S et al. Near-infrared quantum dots for HER2 localization and imaging of cancer cells. Int. J. Nanomed.9, 1323–1337 (2014).
   PubMed Web of Science ®Google Scholar
• Huang Y Deng X Lang J Liang X . Modulation of quantum dots and clearance of Helicobacter pylori with synergy of cell autophagy. Nanomedicine14 (3), 849–861 (2018).
   PubMed Web of Science ®Google Scholar
• Fakayode OJ Tsolekile N Songca SP Oluwafemi OS . Applications of functionalized nanomaterials in photodynamic therapy. Biophys. Rev.10 (1), 49–67 (2018).
   PubMedGoogle Scholar
• Dommermuth R Ewing K . Metabolic syndrome: systems thinking in heart disease. Prim. Care45 (1), 109–129 (2018).
   PubMed Web of Science ®Google Scholar
• Kim D Touros A Kim WR . Nonalcoholic fatty liver disease and metabolic syndrome. Clin. Liver Dis.22 (1), 133–140 (2018).
   PubMed Web of Science ®Google Scholar
• Denoyelle S Chen T Chen L et al. In vitro inhibition of translation initiation by N,N’-diarylureas – potential anti-cancer agents. Bioorg. Med. Chem. Lett.22 (1), 402–409 (2012).
   PubMed Web of Science ®Google Scholar
• Burwick N Zhang MY de la Puente P et al. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leuk. Res.55, 23–32 (2017).
   PubMed Web of Science ®Google Scholar
• Zarei M Barroso E Leiva R et al. Heme-regulated eIF2α kinase modulates hepatic FGF21 and is activated by PPARβ/δ deficiency. Diabetes65 (10), 3185–3199 (2016).
   PubMed Web of Science ®Google Scholar
• Gao W Wang J . Synthetic micro/nanomotors in drug delivery. Nanoscale6 (18), 10486–10494 (2014).
   PubMed Web of Science ®Google Scholar
• Webb GJ Hirschfield GM Lane PJ . OX40, OX40L and autoimmunity: a comprehensive review. Clin. Rev. Allergy Immunol.50 (3), 312–332 (2016).
   PubMed Web of Science ®Google Scholar
• Buchan SL Rogel A Al-Shamkhani A . The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood131 (1), 39–48 (2018).
   PubMed Web of Science ®Google Scholar
• Turaj AH Cox KL Penfold CA et al. Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking. Sci. Rep.8 (1), 2278 (2018).
   PubMedGoogle Scholar